Scott Williams

6PUBLICATIONS
62CO-AUTHORS
Radiation therapyMolecular targetsPredictive and prognostic markersEpidemiological methodsPeripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 06, 2026
Clonal Hematopoiesis after 177Lu-PSMA-617 Radioligand Therapy in Prostate Cancer.

Aslı D Munzur, Cameron Herberts, Edmond M Kwan

|Aug 26, 2022
Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status.

Javier Octavio Mejía-Hernández, Dinesh Raghu, Franco Caramia

|Apr 19, 2022
Evolving Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Hormone-Sensitive Prostate Cancer: More Questions than Answers?

Maha Hussain, Michael A Carducci, Noel Clarke

|Dec 20, 2021
Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP.

Martin R Stockler, Andrew J Martin, Ian D Davis

|Sep 01, 2020
Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting.

Andrea K Miyahira, Kenneth J Pienta, John W Babich

Pageof 1